Cardiac Uptake on a PET Scan: — What That Line in Your Report Means

In most cases, no. Increased myocardial FDG uptake on a cancer PET scan is most often physiological — the heart muscle using glucose as fuel, which is what it does continuously. The phrase sounds alarming but it is a standard observation radiologists make on a large proportion of PET scans. Whether the pattern warrants any additional investigation depends on the specific appearance: diffuse uptake across the whole heart muscle is almost always normal; a focal bright spot in one area is the pattern more likely to prompt further review. Ask your oncologist specifically whether any follow-up was recommended in the radiology report.

Radiology reports describe what was seen, not what the clinical significance is. When a radiologist observes cardiac uptake, their job is to document it and note whether the pattern is typical. Calling it 'normal' is a clinical conclusion that combines the imaging with your specific cancer history — and that synthesis is your oncologist's role, not the radiologist's in isolation. A report that describes uptake without recommending follow-up is, in practical terms, saying the pattern did not concern the radiologist. If you are uncertain what the recommendation is, ask your oncologist to read that section of the report with you.

Only if the radiologist or your oncologist determines the pattern warrants it. A follow-up cardiac investigation is not automatic — it depends on the appearance, your specific cancer, and your medical history. If it is recommended, the most common investigations are a cardiac MRI or an echocardiogram. These are standard, non-invasive tests. If no further cardiac imaging was recommended in the report, you do not need to arrange one yourself. Your oncologist will tell you directly if they want to investigate further.

Yes — and this is a separate question from incidental cardiac uptake on a PET scan. Some chemotherapy drugs, certain targeted therapies, and radiation to the chest area can affect heart function over time. If you are concerned about treatment-related heart effects, ask your oncologist whether your treatment carries any cardiac risk and whether monitoring is already part of your plan. This is an important question to raise, but it is distinct from the question of what an incidental PET finding means.

Fasting and low-carbohydrate dietary preparation before a PET scan reduce cardiac glucose uptake in many patients, but uptake remains variable and cannot be eliminated reliably in everyone. The duration and completeness of the fast, individual metabolism, stress levels, and cardiac workload all influence how much the heart muscle takes up the tracer. A heart that still appears despite good preparation is not a sign that something is wrong — it is a known characteristic of PET imaging that radiologists account for in their reporting.

If you already have a cardiologist involved in your care, it is reasonable to mention the finding at your next appointment. In most cases, the oncologist will determine from the radiology report whether a cardiology referral is needed. If no referral is suggested and your oncologist is not concerned, you do not need to self-refer. If you have existing heart disease and are unsure how this finding relates to it, raise that specifically with your oncologist — the context of your cardiac history changes how the finding should be interpreted.